Coronavirus-infected Bilibid inmate dies, says BuCor official | Inquirer News

Coronavirus-infected Bilibid inmate dies, says BuCor official

/ 09:25 PM April 24, 2020

MANILA, Philippines — The first inmate from the New Bilibid Prison (NBP) to have acquired the novel coronavirus that causes respiratory ailment COVID-19 has died Friday evening, the Bureau of Corrections (BuCor) said.

“Official notification to the next of kin of the PDL was done and the NBP Hospital staff had coordinated with RITM for the proper disposition of the patient’s remains,” BuCor’s Spokesman Col. Gabriel Chaclag said.

BuCor said inmates or persons deprived of liberty (PDLs) that came in contact with the dead inmate and currently undergoing quarantine still have no symptoms of the virus.

Article continues after this advertisement

“Proper health monitoring is being given to improve their stamina and increase their chance of surviving the disease,” Chaclag assured.

FEATURED STORIES
KGA

RELATED STORY

Bilibid inmate is positive of COVID-19

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: Bilibid, Coronavirus, COVID-19

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.